BioTuesdays

Tag - NEO

NeoGenomics

BTIG ups NeoGenomics to buy; PT $11

BTIG upgraded NeoGenomics (NASDAQ:NEO) to “buy” from “neutral” with a price target of $11, saying that with a cleaner slate, it expects the shares to outperform. The stock closed at $8.49 on April 13. Analyst Dr. Sean...